Ladies and Fellas Start your Engines!!!We are ready!!! The presentation today will create the catalyst needed for Greatness and Glory!!!
We have put up with that Bear crap for the last time, now lets make us some millionaires and cure some F**kin Cancer!!
Notes:
OBV: About to Break through top of its Trend!
-Chart shows a slightly modified(Accelerated) Price projection.
-Coming out a strong accumulation phase.
-Continuation of Longer term Cup and Handle.
Buy Buy Buy
Let me know your Thoughts!!!
Biotech
This is going to be HUGE! Moving Averages Confirm!!I noticed a very similar pattern on the Daily where the 9 and 50 MA cross and where the 20 MA will soon Cross. This is an super simple attempt to project what will happen...
The Presentation next week would align well with a breakout!!
Good luck and buy those bags while they are cheap!!
4 HR chart! If it's Tight its right!The 4hr chart looks promising for a decent Scalp. 9,20, and 50 EMA curling up under the price.
-9 EMA just crossed the 20 EMA and both the 9 and 20 EMA are about to cross the 50 EMA
Targets:
- .62 take out 1/2
- .81 all out
Lets see how we do!
Curls for the Girls!! Breakout imminent!!Its been a while since I have published anything but this stock is ready for greatness and glory!! With upcoming news on the horizon ( presentation coming up) and a lot of speculation on potential Merck acquisition. The TA combined is ready to rocket!!!
Notes:
-200, 50, 20, and 9 EMA all curling right under the price(Curls for the girls).. This indicates a Strong level of support and momentum coming into play.
-The Curls for the Girls is the powerhouse setup needed for breaking through this Bullish pennant.
I hope you all buy now before I buy it all up!!!
Good Luck. Let me know your Thoughts!
On the watch for potential breakoutBavarian Nordic
is a fully integrated biotechnology company focused on the development, manufacturing and commercialization of cancer immunotherapies and vaccines for infectious diseases.
Is yet again testing the resistance at 200. The grey area is a 5 year previous Support/resistance zone, been tested multiple times.
Break out could lead to a significant rally
it goes on the watch list for now.
Dip buy with a coronaThe Beijing branch of China’s National Health Commission said a combination of lopinavir and ritonavir, sold under the brand name Kaletra by AbbVie, is part of its latest treatment plan for patients infected by the Coronavirus, which has killed at 81 people in China and sickened more than 2,800 worldwide.
After breaking out of the downtrend, ABBV is coming back to retest the channel, support area and weekly 50 moving average.
In terms of valuation, ABBV is currently trading at a Forward P/E ratio of 9. For comparison, its industry has an average Forward P/E of 15.48, which means ABBV is trading at a discount to the group.
ABBV will be looking to display strength as it nears its next earnings release, which is expected to be February 7, 2020. In that report, analysts expect ABBV to post earnings of $2.20 per share. This would mark year-over-year growth of 15.79%
ABBV should soon find support for a bounceAbbvie has been falling hard on news that it will sell off some drug patents in order to win approval for its merger with Allergan. It is entering a support zone between about $77 and $81, however, and it may start to climb from here as investors start to get excited about the merger. Also look for Coronavirus news to move the stock; word on the street is that one of Abbvie's drugs is being used off-label to treat Coronavirus patients.
With a 5.67% dividend yield and a forward P/E under 10, ABBV looks attractively valued. True, the patent sales will probably negatively affect that forward P/E, and the merger might ultimately result in a lower dividend yield. But Abbvie will also pocket a bunch of cash from those drug sales that can be used to grow its pipeline, and Allergan's forward P/E is also low, with plenty of potential upside.
Re-Evaluated Falling Wedge, still BullishI reevaluated the falling wedge and it occurred to me. This was was a failed wedge that created a new falling wedge ( Note Dark Gray lines vs. White lines).
Here are my latest notes:
-The Last 2 days have show a strong support around $ 0.77 which is also the 50 day MA.
-Stochastic: Showing a strong Divergence as well as being oversold.
-On Balance Volume: Still trending upward and holding its positive volume through the last couple weeks price decrease ( Serious bullish signal).
-This may not cure the Coronavirus, but HELLO it could Cure CANCER!!! Last time I checked People hated cancer more than the Coronavirus( Sorry for the rant)
We are still need a catalyst (News!!!!), But patience is a rough thing for most ( I mean hell I have ADHD, but I haven't left yet).
Holding strong, Bullish as F**K, and Remember BUY BUY BUY!!!
If you like my analysis follow me! If you have an opinion, Please let me know!! Multiple Opinions are better than one!
I may not always be right but even when I am wrong I do it with Style!
ISEE 3.0 Risk-RewardISEE broke out from a long-time base with tremendous volume.
It pulled back and built a small base.
At the time, although it may be not the best win-lose position, it has the best risk-reward.
No pain no gain still on track4hr chart is still clean on the falling wedge. Just like many one day dips in the market this could rocket back hard tomorrow!! Buy buy buy
Buckle up! Falling Wedge pattern on Daily Ready to Rocket!Perfect close yesterday to bounce off support into a major move up! This is what we have been waiting for!
Notes:
-Stochastic: is sitting in a good spot: Neutral ( Not oversold or Over bought)
-On Balance Volume: Still trending up on the daily very strong sign, especially with the price decline in the short term, The OBV hints at strong momentum still.
-Falling Wedge: Setup is perfect. Its very clean and we are in a good spot!
-20 MA: to 20 moving average is a great support and sets up for a larger stronger bounce after a deep pullback like this.
-SSR in place today so Bulls can really have an advantage here!
-Pre Market: Off to a hot start!
Good Luck and Buy Buy Buy!!!!
Still Bullish... Daily pattern holding..The daily chart Still playing out a much larger Falling wedge, Still Bullish! If we close above $1.01 ( right at the 20 MA) we are still if a great place! Better discount buy opportunities right now! Remember Sometimes you have to go down a little for a large jump!!! Literally think about jumping off the ground.... you bend your knees get really low and then leap into clouds of money!!!
American cancer vaccine patent boost $PCIB.OL over falling wedgePCI Biotech: US patent granted for the vaccine technology (fimaVACC) in combination with cytokines
Oslo (Norway), 21 January 2020 – PCI Biotech OSL:PCIB , a cancer focused biopharmaceutical company, today announces that the U.S. Patent and Trademark Office (USPTO) has granted the company a US patent covering the use of fimaVacc in combination with cytokines.
Cytokines are small proteins that are involved in cell signaling, and that are very important in the immune system, modulating both cell-based and humoral immune responses. The combination of cytokines with PCI Biotech’s vaccine technology, fimaVacc, has been shown to be effective for enhancing cellular immune responses that are important for the effect of therapeutic vaccines. The now granted US patent gives broad coverage for the combination of various cytokines with the fimaVacc technology.
There are many vaccines under development utilising cytokines to elicit immune responses. The US patent granted today is important for PCI Biotech’s development strategy, as it supplements our ability to generate an internal future vaccine pipeline, in addition to bringing value for the fimaVacc technology in partnering efforts, said Per Walday, CEO of PCI Biotech.
As part of PCI Biotech’s strategy for applying the PCI-technology for therapeutic cancer vaccines, several global patent applications were filed in 2013 and 2014. Today’s granted US patent secure protection until 2035 and this patent application is still pending in Europe and key Asian markets.
Press release direct URL:
pcibiotech.no
Nasdaq Healthcare: Closing on January 17thFriday's session presented a retracement on the 20 EMA Line, as predicted. I still believe in the continuation of the bullish trend. However, the bearish divergence needs to be monitored, since further price correction could occur.
Disclosure: My ideas contain statements and projections based on assumptions on capital markets, and therefore inherently subject to numerous risks and uncertainties.
Before buying or selling any stock you should do your own research and reach your own conclusion or consult a financial advisor. Investing includes risks, including loss of principal.
I am not a financial advisor
Possible rough next week for MRNA - possible reverse H&S formingTechnical RSI, MACD and momentum indicator (Lazybear) and chart looks like Moderna will be falling this week (8% +/- 5%) I plan to accumulate on dips into the $19 area while looking at charts.
To confirm the formation of reverse head and shoulders, the nice symmetrical MACD and momentum swings with RSI reaching a bottom would confirm MRNA is poised to break through that 21.50 ish resistant after next week.
1Hr chart setting up nice for a Bounce off 9EMAThe 9 EMA should be a nice bounce point. Watch the Stochastic, needs to cool off a little bit before we Take off!!